Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

IGC Relative to the S&P 500

IGC Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the India Globalization Capital, Inc. (AMEX:IGC) seasonal charts above shows that a Buy Date of January 1 and a Sell Date of March 28 has resulted in a geometric average return of 12.14% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 43.91% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer’s disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer’s disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer’s and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer’s research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

To download IGC seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: IGC